| Repurposing the CRISPR-Cas9 system for targeted DNA methylation A Vojta, P Dobrinić, V Tadić, L Bočkor, P Korać, B Julg, M Klasić, V Zoldoš Nucleic acids research 44 (12), 5615-5628, 2016 | 861 | 2016 |
| CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity V Tadić, G Josipović, V Zoldoš, A Vojta Methods 164, 109-119, 2019 | 59 | 2019 |
| Antagonistic and synergistic epigenetic modulation using orthologous CRISPR/dCas9-based modular system G Josipović, V Tadić, M Klasić, V Zanki, I Bečeheli, F Chung, A Ghantous, ... Nucleic acids research 47 (18), 9637-9657, 2019 | 53 | 2019 |
| A transient expression system with stably integrated CRISPR-dCas9 fusions for regulation of genes involved in immunoglobulin G glycosylation A Mijakovac, K Miškec, J Krištić, V Vičić Bočkor, V Tadić, M Bošković, ... The CRISPR Journal 5 (2), 237-253, 2022 | 9 | 2022 |
| Tuning the coordination properties of chiral pseudopeptide bis (2-picolyl) amine and iminodiacetamide ligands in Zn (ii) and Cu (ii) complexes NP Juraj, T Tandarić, V Tadić, B Perić, D Moreth, U Schatzschneider, ... Dalton transactions 51 (44), 17008-17021, 2022 | 7 | 2022 |
| Carboplatin-induced upregulation of pan β-tubulin and class III β-tubulin is implicated in acquired resistance and cross-resistance of ovarian cancer M Pernar Kovač, V Tadić, J Kralj, GE Duran, A Stefanelli, ... Cellular and molecular life sciences 80 (10), 294, 2023 | 4 | 2023 |
| Selenium-substituted monomethine cyanine dyes as selective G-quadruplex spectroscopic probes with theranostic potential I Fabijanić, A Kurutos, A Tomašić Paić, V Tadić, FS Kamounah, L Horvat, ... Biomolecules 13 (1), 128, 2023 | 4 | 2023 |
| The high-grade serous ovarian cancer metastasis and chemoresistance in 3D models V Tadić, W Zhang, A Brozovic Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 189052, 2023 | 2 | 2023 |
| Late transition metal complexes of ferrocene‐containing nitrogen ligands: Coordination chemistry, electron transfer properties, and tumor cell viability S Jakopec, N Pantalon Juraj, D Jadreško, R Vianello, A Brozovic, V Tadić, ... Applied organometallic chemistry, e7415, 2024 | | 2024 |
| MiRNA-mRNA integrative analysis reveals epigenetically regulated and prognostic miR-103a with a role in migration and invasion of carboplatin-resistant ovarian cancer cells … MP Kovač, V Tadić, J Kralj, MM Periša, S Orešković, I Babić, V Banović, ... Biomedicine & Pharmacotherapy 166, 115349, 2023 | | 2023 |
| MiRNA-mRNA integrative analysis reveals epigenetically regulated and prognostic miR-103a with a role in migration and invasion of carboplatin-resistant ovarian cancer cells … M Pernar Kovač, V Tadić, J Kralj, M Milković Periša, S Orešković, I Babić, ... Biomedicine & pharmacotherapy 116, 115349, 2023 | | 2023 |
| Different expression of DNMT1, PCNA, MCM2, CDT1, EZH2, GMNN and EP300 genes in lymphomagenesis of low vs. high grade lymphoma KH Pavlov, V Tadić, PB Palković, B Sasi, N Magdić, MZ Petranović, ... Pathology-Research and Practice 239, 154170, 2022 | | 2022 |
| The miR-200c/TUBB3 Regulatory Axis is Part of the Cellular Stress Response to Carboplatin in Drug-resistant Ovarian Cancer Cell Lines M Pernar Kovač, V Tadić, J Kralj, D Stupin Polančec, S Dabelić, ... 6th Meeting of the Croatian Association for Cancer Research with …, 2022 | | 2022 |
| The interplay between tubulin β isotypes and drug response in ovarian cancer cell lines resistant to carboplatin M Pernar Kovač, V Tadić, J Kralj, GE Duran, A Stefanelli, ... Congress of the Croatian Society of Biochemistry and Molecular Biology: From …, 2022 | | 2022 |
| MCM2, PCNA i EZH2 u limfomagenezi K Horvat Pavlov, V Tadić, P Bašić Palković, B Sasi, N Magdić, M Klasić, ... 4. simpozijum biologa i ekologa Republike Srpske (SBERS 2020), 67-68, 2020 | | 2020 |
| Construction of molecular tools based on CRISPR/Cas9 system for epigenetic modulation of gene expression V Tadić University of Zagreb. Faculty of Science. Department of Biology, 2019 | | 2019 |
| Prinosi krme i pojava korova u lucerni, smjesama s travama i esparzeti V Tadić, R Gantner, G Bukvić, M Ravlić 54. hrvatski i 14. međunarodni simpozij agronoma, 128-129, 2019 | | 2019 |
| Editing the epigenome using a comprehensive CRISPR/Cas9-based molecular toolbox A Vojta, G Josipović, V Tadić, V Zoldoš 5th Central-Eastern European Congress on Cell-Free Nucleic Acids, 47-47, 2018 | | 2018 |
| CRISPR/Cas9-based molecular tools for epigenetic manipulations V Tadić, P Dobrinić, G Josipović, V Zanki, M Klasić, A Vojta, V Zoldoš ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic …, 2017 | | 2017 |
| Modulation of glyco-gene expression using CRISPR/Cas9-based molecular tools for epigenetic editing A Vojta, P Dobrinić, V Tadić, G Josipović, V Zanki, M Klasić, V Zoldoš International Symposium on Glycoconjugates (24; 2017), 51-51, 2017 | | 2017 |
Vlatka ZoldošFaculty of Science, University of ZagrebVerified email at biol.pmf.hr
